Role of interleukin-6 in a patient with tumor necrosis factor receptor–associated periodic syndrome: Assessment of outcomes following treatment with the anti–interleukin-6 receptor monoclonal antibody tocilizumab

✍ Scribed by Prashantha M. Vaitla; Paul M. Radford; Patrick J. Tighe; Richard J. Powell; Elizabeth M. McDermott; Ian Todd; Elizabeth Drewe

• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 112 KB
• Volume: 63
• Category: Article
• ISSN: 0004-3591
• DOI: 10.1002/art.30215